Skip to main content
Erschienen in: Die Ophthalmologie 1/2023

16.12.2022 | Trockenes Auge | Leitlinien, Stellungnahmen und Empfehlungen

Okuläre Graft-Versus-Host Erkrankung

Leitlinie der Deutschen Ophthalmologischen Gesellschaft (DOG) und des Berufsverbands der Augenärzte Deutschlands e. V. (BVA)

verfasst von: Deutsche Ophthalmologische Gesellschaft (DOG), Berufsverband der Augenärzte Deutschlands e. V. (BVA)

Erschienen in: Die Ophthalmologie | Sonderheft 1/2023

Einloggen, um Zugang zu erhalten

Zusammenfassung

Leitlinien sind Orientierungshilfen im Sinne von „Handlungs- und Entscheidungskorridoren“, von denen in begründeten Fällen abgewichen werden kann oder sogar muss. Sie beschreiben, was Augenärzte für eine angemessene Patientenversorgung in der Praxis für geboten halten. Dies entspricht in vielen Fällen nicht dem Leistungsniveau der gesetzlichen Krankenversicherung in Deutschland (s. Präambel).
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Newman RG et al (2013) The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success. Immunol Res 57(1):125–139CrossRef Newman RG et al (2013) The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success. Immunol Res 57(1):125–139CrossRef
2.
Zurück zum Zitat Inamoto Y et al (2019) Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the late effects and quality of life working committee of the CIBMTR and transplant complications working party of the EBMT. Bone Marrow Transplant 54(5):648–661CrossRef Inamoto Y et al (2019) Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the late effects and quality of life working committee of the CIBMTR and transplant complications working party of the EBMT. Bone Marrow Transplant 54(5):648–661CrossRef
3.
Zurück zum Zitat Dietrich-Ntoukas T et al (2012) Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss consensus conference on clinical practice in chronic GVHD. Cornea 31(3):299–310CrossRef Dietrich-Ntoukas T et al (2012) Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss consensus conference on clinical practice in chronic GVHD. Cornea 31(3):299–310CrossRef
4.
Zurück zum Zitat Filipovich AH et al (2005) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11(12):945–956CrossRef Filipovich AH et al (2005) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11(12):945–956CrossRef
5.
Zurück zum Zitat Na KS et al (2015) Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 50(11):1459–1464CrossRef Na KS et al (2015) Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 50(11):1459–1464CrossRef
6.
Zurück zum Zitat Westekemper H et al (2017) Ocular graft versus host disease : corneal complications. Ophthalmologe 114(8):697–702CrossRef Westekemper H et al (2017) Ocular graft versus host disease : corneal complications. Ophthalmologe 114(8):697–702CrossRef
7.
Zurück zum Zitat Giannaccare G et al (2019) Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle. Graefes Arch Clin Exp Ophthalmol 257(7):1341–1351CrossRef Giannaccare G et al (2019) Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle. Graefes Arch Clin Exp Ophthalmol 257(7):1341–1351CrossRef
8.
Zurück zum Zitat Hu B, Qiu Y, Hong J (2020) Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD). Ocul Surf 18(2):298–304CrossRef Hu B, Qiu Y, Hong J (2020) Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD). Ocul Surf 18(2):298–304CrossRef
10.
Zurück zum Zitat Mirza N et al (2016) Graft versus self (GvS) against T‑cell autoantigens is a mechanism of graft-host interaction. Proc Natl Acad Sci U S A 113(48):13827–13832CrossRef Mirza N et al (2016) Graft versus self (GvS) against T‑cell autoantigens is a mechanism of graft-host interaction. Proc Natl Acad Sci U S A 113(48):13827–13832CrossRef
11.
Zurück zum Zitat Mohty M et al (2002) Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 100(9):3128–3134CrossRef Mohty M et al (2002) Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 100(9):3128–3134CrossRef
12.
Zurück zum Zitat Steven P et al (2015) Semifluorinated alkane eye drops for treatment of dry eye disease—a prospective, multicenter noninterventional study. J Ocul Pharmacol Ther 31(8):498–503CrossRef Steven P et al (2015) Semifluorinated alkane eye drops for treatment of dry eye disease—a prospective, multicenter noninterventional study. J Ocul Pharmacol Ther 31(8):498–503CrossRef
13.
Zurück zum Zitat Hessen M, Akpek EK (2012) Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 12(5):540–547CrossRef Hessen M, Akpek EK (2012) Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 12(5):540–547CrossRef
14.
Zurück zum Zitat Inamoto Y et al (2019) Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the late effects and quality of life working committee of the CIBMTR and transplant complications working party of the EBMT. Bone Marrow Transplant 54(5):662–673CrossRef Inamoto Y et al (2019) Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the late effects and quality of life working committee of the CIBMTR and transplant complications working party of the EBMT. Bone Marrow Transplant 54(5):662–673CrossRef
16.
Zurück zum Zitat Espana EM et al (2013) Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol 251(5):1257–1266CrossRef Espana EM et al (2013) Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol 251(5):1257–1266CrossRef
17.
Zurück zum Zitat Jabs DA et al (1989) The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 107(9):1343–1348CrossRef Jabs DA et al (1989) The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 107(9):1343–1348CrossRef
18.
Zurück zum Zitat Jagasia MH et al (2015) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant 21(3):389–401.e1CrossRef Jagasia MH et al (2015) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant 21(3):389–401.e1CrossRef
19.
Zurück zum Zitat Giannaccare G et al (2019) In vivo confocal microscopy morphometric analysis of corneal subbasal nerve plexus in dry eye disease using newly developed fully automated system. Graefes Arch Clin Exp Ophthalmol 257(3):583–589CrossRef Giannaccare G et al (2019) In vivo confocal microscopy morphometric analysis of corneal subbasal nerve plexus in dry eye disease using newly developed fully automated system. Graefes Arch Clin Exp Ophthalmol 257(3):583–589CrossRef
20.
Zurück zum Zitat Versura P et al (2013) Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye. Cornea 32(4):412–418CrossRef Versura P et al (2013) Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye. Cornea 32(4):412–418CrossRef
21.
Zurück zum Zitat Berchicci L et al (2014) Tear osmolarity in ocular graft-versus-host disease. Cornea 33(12):1252–1256CrossRef Berchicci L et al (2014) Tear osmolarity in ocular graft-versus-host disease. Cornea 33(12):1252–1256CrossRef
22.
Zurück zum Zitat Schargus M et al (2015) Correlation between tear film osmolarity and the disease score of the international chronic ocular graft-versus-host-disease consensus group in hematopoietic stem cell transplantation patients. Cornea 34(8):911–916CrossRef Schargus M et al (2015) Correlation between tear film osmolarity and the disease score of the international chronic ocular graft-versus-host-disease consensus group in hematopoietic stem cell transplantation patients. Cornea 34(8):911–916CrossRef
23.
Zurück zum Zitat Ban Y et al (2011) Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. Mol Vis 17:2533 Ban Y et al (2011) Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. Mol Vis 17:2533
24.
Zurück zum Zitat He J et al (2017) In vivo confocal microscopy evaluation of ocular surface with graft-versus-host disease-related dry eye disease. Sci Rep 7(1):10720CrossRef He J et al (2017) In vivo confocal microscopy evaluation of ocular surface with graft-versus-host disease-related dry eye disease. Sci Rep 7(1):10720CrossRef
25.
Zurück zum Zitat Steger B et al (2015) In vivo confocal microscopic characterisation of the cornea in chronic graft-versus-host disease related severe dry eye disease. Br J Ophthalmol 99(2):160–165CrossRef Steger B et al (2015) In vivo confocal microscopic characterisation of the cornea in chronic graft-versus-host disease related severe dry eye disease. Br J Ophthalmol 99(2):160–165CrossRef
26.
Zurück zum Zitat Giannaccare G et al (2019) Corneal biomechanical alterations in patients with chronic ocular graft versus-host disease. PLoS One 14(4):e213117CrossRef Giannaccare G et al (2019) Corneal biomechanical alterations in patients with chronic ocular graft versus-host disease. PLoS One 14(4):e213117CrossRef
27.
Zurück zum Zitat Abud TB et al (2016) A clinical trial comparing the safety and efficacy of topical tacrolimus versus methylprednisolone in ocular graft-versus-host disease. Ophthalmology 123(7):1449–1457CrossRef Abud TB et al (2016) A clinical trial comparing the safety and efficacy of topical tacrolimus versus methylprednisolone in ocular graft-versus-host disease. Ophthalmology 123(7):1449–1457CrossRef
28.
Zurück zum Zitat Dastjerdi MH, Hamrah P, Dana R (2009) High-frequency topical cyclosporine 0.05 % in the treatment of severe dry eye refractory to twice-daily regimen. Cornea 28(10):1091–1096CrossRef Dastjerdi MH, Hamrah P, Dana R (2009) High-frequency topical cyclosporine 0.05 % in the treatment of severe dry eye refractory to twice-daily regimen. Cornea 28(10):1091–1096CrossRef
29.
Zurück zum Zitat Wan KH, Chen LJ, Young AL (2015) Efficacy and safety of topical 0.05 % cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 13(3):213–225CrossRef Wan KH, Chen LJ, Young AL (2015) Efficacy and safety of topical 0.05 % cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 13(3):213–225CrossRef
30.
Zurück zum Zitat Dignan FL et al (2012) Organ-specific management and supportive care in chronic graft-versus-host disease. Br J Haematol 158(1):62–78CrossRef Dignan FL et al (2012) Organ-specific management and supportive care in chronic graft-versus-host disease. Br J Haematol 158(1):62–78CrossRef
31.
Zurück zum Zitat Ervin AM, Law A, Pucker AD (2019) Punctal occlusion for dry eye syndrome: summary of a Cochrane systematic review. Br J Ophthalmol 103(3):301–306CrossRef Ervin AM, Law A, Pucker AD (2019) Punctal occlusion for dry eye syndrome: summary of a Cochrane systematic review. Br J Ophthalmol 103(3):301–306CrossRef
32.
Zurück zum Zitat Sabti S et al (2012) Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD. Bone Marrow Transplant 47(7):981–984CrossRef Sabti S et al (2012) Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD. Bone Marrow Transplant 47(7):981–984CrossRef
33.
Zurück zum Zitat Jacobs DS, Rosenthal P (2007) Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea 26(10):1195–1199CrossRef Jacobs DS, Rosenthal P (2007) Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea 26(10):1195–1199CrossRef
35.
Zurück zum Zitat Ogawa Y et al (2003) Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 31(7):579–583CrossRef Ogawa Y et al (2003) Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 31(7):579–583CrossRef
36.
Zurück zum Zitat Tahmaz V et al (2017) Treatment of severe chronic ocular graft-versus-host disease using 100 % autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study. Br J Ophthalmol 101(3):322–326 Tahmaz V et al (2017) Treatment of severe chronic ocular graft-versus-host disease using 100 % autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study. Br J Ophthalmol 101(3):322–326
37.
Zurück zum Zitat Inagaki E et al (2011) Four cases of corneal perforation in patients with chronic graft-versus-host disease. Mol Vis 17:598–606 Inagaki E et al (2011) Four cases of corneal perforation in patients with chronic graft-versus-host disease. Mol Vis 17:598–606
38.
Zurück zum Zitat Yeh PT et al (2006) Recurrent corneal perforation and acute calcareous corneal degeneration in chronic graft-versus-host disease. J Formos Med Assoc 105(4):334–339CrossRef Yeh PT et al (2006) Recurrent corneal perforation and acute calcareous corneal degeneration in chronic graft-versus-host disease. J Formos Med Assoc 105(4):334–339CrossRef
39.
Zurück zum Zitat Peris-Martinez C et al (2001) Multilayer amniotic membrane transplantation in severe ocular graft versus host disease. Eur J Ophthalmol 11(2):183–186CrossRef Peris-Martinez C et al (2001) Multilayer amniotic membrane transplantation in severe ocular graft versus host disease. Eur J Ophthalmol 11(2):183–186CrossRef
40.
Zurück zum Zitat Shah A, Santhiago MR, Espana EM (2016) Cataract surgery in patients with chronic severe graft-versus-host disease. J Cataract Refract Surg 42(6):833–839CrossRef Shah A, Santhiago MR, Espana EM (2016) Cataract surgery in patients with chronic severe graft-versus-host disease. J Cataract Refract Surg 42(6):833–839CrossRef
41.
Zurück zum Zitat Claessens D, Schuster AK (2019) Correlation of Quantitative Metamorphopsia Measurement and Central Retinal Thickness in Diabetic Macular Edema and Age-Related Exsudative Macular Degeneration. Klin Monbl Augenheilkd 236(7):877–884. https://doi.org/10.1055/s-0043-125080. Epub 2018 Feb 28CrossRef Claessens D, Schuster AK (2019) Correlation of Quantitative Metamorphopsia Measurement and Central Retinal Thickness in Diabetic Macular Edema and Age-Related Exsudative Macular Degeneration. Klin Monbl Augenheilkd 236(7):877–884. https://​doi.​org/​10.​1055/​s-0043-125080. Epub 2018 Feb 28CrossRef
Metadaten
Titel
Okuläre Graft-Versus-Host Erkrankung
Leitlinie der Deutschen Ophthalmologischen Gesellschaft (DOG) und des Berufsverbands der Augenärzte Deutschlands e. V. (BVA)
verfasst von
Deutsche Ophthalmologische Gesellschaft (DOG)
Berufsverband der Augenärzte Deutschlands e. V. (BVA)
Publikationsdatum
16.12.2022
Verlag
Springer Medizin
Erschienen in
Die Ophthalmologie / Ausgabe Sonderheft 1/2023
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-022-01781-6

Weitere Artikel der Sonderheft 1/2023

Die Ophthalmologie 1/2023 Zur Ausgabe

Leitlinien, Stellungnahmen und Empfehlungen

Retinale arterielle Verschlüsse (RAV)

Leitlinien, Stellungnahmen und Empfehlungen

Virale anteriore Uveitis

Passend zum Thema

DKK 2024
21. - 24. Februar 2024 | Berlin

Kongressdossier zum Deutschen Krebskongress 2024

Erfahren Sie auf dieser Seite, was auf dem DKK 2024 diskutiert wurde. Es ging um den Stellenwert der Künstlichen Intelligenz in der Onkologie, um Innovationen bei Ovarial- und Glioblastom oder die teils gravierenden Nebenwirkungen von Checkpoint-Inhibitoren. Außerdem lesen Sie zu den Dos und Don’ts des molekularpathologischen Befundberichts.

In Kooperation mit:
Deutsche Krebsgesellschaft e. V. und Stiftung Deutsche Krebshilfe